Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

6,775 total articles

Sharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury Strategy

Sharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury Strategy

Sharps Technology transformed its financial position in 2025 by implementing a Solana-based digital asset treasury strategy, accumulating over 2 million SOL, achieving nearly $7 million in staking revenue, and significantly expanding its asset base, while phasing out unprofitable manufacturing operations to create a scalable, capital-efficient busi…

MidCap Financial Investment Corporation Schedules Earnings Release and Conference Call for Quarter Ended March 31, 2026

MidCap Financial Investment Corporation Schedules Earnings Release and Conference Call for Quarter Ended March 31, 2026

MidCap Financial Investment Corporation (NASDAQ: MFIC) has scheduled its earnings report for the quarter ended March 31, 2026, to be released after market close on May 6, 2026. The company will host a conference call on May 7, 2026, to discuss results. MidCap Financial is a diversified business development company primarily investing in first lien …

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application

NRx Pharmaceuticals announced the FDA's preliminary alignment on the labeling for its preservative-free ketamine product under its generic drug application, with anticipated approval expected in Summer 2026. This product could help address current ketamine supply shortages in the U.S. and aligns with national priorities on domestic drug manufacturi…

Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital

Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital

Opus Genetics, a clinical-stage biotech company specializing in gene therapies for inherited retinal diseases, announced a strategic financing agreement with Oberland Capital providing up to $155 million in non-dilutive funding to accelerate clinical development and potential commercialization of its gene therapy pipeline. The initial $35 million t…

Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET

Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET

Agios Pharmaceuticals, a commercial-stage biopharmaceutical company focused on rare diseases, announced it will host a conference call and live webcast on April 29, 2026 to report its Q1 2026 financial results and business updates. The webcast will be accessible via the investor section of the company website, with a replay available shortly after …

Treasure Global Reappoints Former CEO Sam Teo as Acting CEO to Lead Next Phase of Growth; Carlson Thow to Continue as Executive Director

Treasure Global Reappoints Former CEO Sam Teo as Acting CEO to Lead Next Phase of Growth; Carlson Thow to Continue as Executive Director

Treasure Global Inc. reappoints Sam Teo as Acting CEO to lead the company's next growth phase, focusing on scaling its ZCITY platform, fintech, e-commerce, and emerging technology verticals. Carlson Thow steps down as CEO but remains as Executive Director to support strategic initiatives. The company reports strong user engagement and significant A…

Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Sagimet Biosciences announced presentations at the Fueling MASH Keystone Symposium detailing analysis from their Phase 2b FASCINATE-2 trial of denifanstat in MASH patients, showing significant reductions in bile acid biomarkers correlated with fibrosis and MASH resolution. Additionally, the company granted inducement options to a new employee under…

Exponent Elevates John Pye to President and Eric Anderson to CFO Reporting to Catherine Corrigan, CEO; Rich Schlenker to Remain as Executive VP and to Stand for Election to Board of Directors

Exponent Elevates John Pye to President and Eric Anderson to CFO Reporting to Catherine Corrigan, CEO; Rich Schlenker to Remain as Executive VP and to Stand for Election to Board of Directors

Exponent, Inc., a leading engineering and scientific consulting firm, announced key leadership changes effective May 1, 2026. John Pye is promoted to President, bringing extensive technical and leadership experience, while Eric Anderson is appointed CFO, leveraging his financial expertise and operational insight. Additionally, Richard Schlenker wil…

Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention

Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention

Medicus Pharma Ltd. announced the submission of an optimized Phase 2 clinical study protocol for Teverelix, its investigational GnRH antagonist, to the U.S. FDA. The study targets prevention of recurrent acute urinary retention in men with benign prostatic hyperplasia. The new study design reduces sample size and cost, aiming for rapid generation o…

Neuronetics Announces Chief Financial Officer Transition

Neuronetics Announces Chief Financial Officer Transition

Neuronetics, Inc., a Nasdaq-listed medical technology company specializing in neurohealth solutions including the NeuroStar Advanced Therapy System, announced the upcoming departure of CFO Steven E. Pfanstiel effective May 1, 2026. The company has initiated a search for his replacement and reaffirmed its previously issued financial guidance for 202…

nCino Analyst Digital Partner Cuts Commercial Relationship Review Time by Up to 70%, Enabling Financial Institutions to Build an AI-Augmented Credit Workforce

nCino Analyst Digital Partner Cuts Commercial Relationship Review Time by Up to 70%, Enabling Financial Institutions to Build an AI-Augmented Credit Workforce

nCino, Inc. announced significant customer success with its Analyst Digital Partner AI agent, which reduces commercial banking relationship review times from days to hours. The AI agent, built on extensive banking-specific data, allows credit teams to handle reviews 60-70% faster, enabling more frequent and proactive risk management. The solution i…

Streamex Corp. Announces Webcast Details for Wednesday, April 8 Earnings and Corporate Update Presentation

Streamex Corp. Announces Webcast Details for Wednesday, April 8 Earnings and Corporate Update Presentation

Streamex Corp. (NASDAQ: STEX), a technology and infrastructure company engaged in tokenization of commodity real-world assets, announced a webcast scheduled for April 8, 2026, to present its 2025 financial results, product updates including the GLDY launch, and a strategic roadmap for 2026 and beyond. The webcast will include management's recap of …

Papa Johns Canada Introduces Spinach Alfredo Chicken Tomato Pizza

Papa Johns Canada Introduces Spinach Alfredo Chicken Tomato Pizza

Papa Johns Canada has introduced a new limited-time pizza offering, the Spinach Alfredo Chicken Tomato Pizza, featuring a creamy spinach Alfredo sauce, grilled chicken, and fresh-cut Roma tomatoes. Available from April 6 to May 24, the pizza aims to offer customers a comforting and flavorful alternative to traditional tomato-based pizzas. Papa John…

Wabash Schedules First Quarter 2026 Earnings Conference Call

Wabash Schedules First Quarter 2026 Earnings Conference Call

Wabash (NYSE: WNC), a manufacturer of transportation and logistics solutions, has scheduled its quarterly earnings conference call for May 1, 2026, at 12:00 p.m. ET. The company will webcast the call, along with an accompanying slide presentation, on its investor website. Earnings press releases and related materials will be available prior to the …

NorthStrive Defense Tech Acquires Multi-Domain Drone Payload Technology Option for Defense and Commercial Applications

NorthStrive Defense Tech Acquires Multi-Domain Drone Payload Technology Option for Defense and Commercial Applications

PMGC Holdings Inc., through its subsidiary NorthStrive Defense Tech, has acquired an exclusive option agreement to license a novel drone system patent that enables multi-domain payload transport across air and water, aiming to enhance efficiency and operational capability in defense applications such as littoral logistics and sensor deployment. The…